Literature DB >> 22095933

Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging.

Hyeon Tae Jeong1, Myeong-Jin Kim, Mi-Suk Park, Jin-Young Choi, Jin Sub Choi, Kyung Sik Kim, Gi Hong Choi, Sang-Joon Shin.   

Abstract

PURPOSE: To assess the incremental value of hepatobiliary phase images in gadoxetate disodium-enhanced magnetic resonance imaging (MRI), and to compare diagnostic accuracy and lesion conspicuity on 10- and 20-minute delayed images for preoperative detection of hepatic metastases with subgroup analysis according to size and history of chemotherapy.
MATERIALS AND METHODS: Forty-six patients with 107 metastases who underwent surgery after gadoxetate disodium-enhanced MRI were evaluated. Four observers independently interpreted three sets: dynamic set comprising precontrast T1-, T2-weighted, and dynamic images; 10-minute set comprising dynamic set and 10-minute delayed; 20-minute set comprising 10-minute set and 20-minute delayed. Diagnostic accuracy was compared with subgroup analysis. Liver-to-lesion signal ratio (SR) was calculated using the region of interest method and compared.
RESULTS: Mean A(z) and sensitivities were significantly higher for 10- (A(z) = 0.894, sensitivity = 95.6%) and 20-minute (0.910, 97.2%) than dynamic set (0.813, 79.9%) (P < 0.001), with no significant difference between 10- and 20-minute sets (P = 0.140). In patients with small (≤1 cm) metastases and a history of chemotherapy, sensitivities were significantly higher with 10- (88.2%) and 20-minute (91.6%) sets than dynamic set (48.6%) (P < 0.001). SR was significantly higher for 10- and 20-minute delayed than precontrast and dynamic, with significantly higher SR on 20- than 10-minute delayed.
CONCLUSION: Regardless of size or prior chemotherapy, detection of hepatic metastases was significantly improved by adding hepatobiliary phase images without significant differences between 10- and 20-minute delayed.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095933     DOI: 10.1002/jmri.22880

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  18 in total

1.  Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard.

Authors:  Eduardo A C Costa; Guilherme M Cunha; Emmanuil Smorodinsky; Irene Cruite; An Tang; Robert M Marks; Lisa Clark; Tanya Wolfson; Anthony Gamst; Jason K Sicklick; Alan Hemming; Michael R Peterson; Michael S Middleton; Claude B Sirlin
Journal:  Radiology       Date:  2015-04-15       Impact factor: 11.105

Review 2.  Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.

Authors:  Stefano Palmucci
Journal:  World J Hepatol       Date:  2014-07-27

3.  An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging.

Authors:  Utaroh Motosugi; Peter Bannas; Candice A Bookwalter; Katsuhiro Sano; Scott B Reeder
Journal:  Radiology       Date:  2015-10-16       Impact factor: 11.105

4.  Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.

Authors:  Mi Hye Yu; Jeong Min Lee; Bo Yun Hur; Tae-You Kim; Seung-Yong Jeong; Nam-Joon Yi; Kyung-Suk Suh; Joon Koo Han; Byung-Ihn Choi
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

5.  Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.

Authors:  Mustafa R Bashir; Steven R Breault; Ryan Braun; Richard K Do; Rendon C Nelson; Scott B Reeder
Journal:  Acad Radiol       Date:  2014-04-06       Impact factor: 3.173

6.  Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography.

Authors:  Thomas A Hope; Rizwan Aslam; Stefanie Weinstein; Benjamin M Yeh; Carlos U Corvera; Alex Monto; Judy Yee
Journal:  J Comput Assist Tomogr       Date:  2017 May/Jun       Impact factor: 1.826

7.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.

Authors:  Valérie Vilgrain; Maxime Esvan; Maxime Ronot; Aurore Caumont-Prim; Christophe Aubé; Gilles Chatellier
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

8.  The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion.

Authors:  Amy B Kolbe; Daniel J Podberesky; Bin Zhang; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2014-09-23

9.  Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis.

Authors:  Dahye Lee; Eun-Suk Cho; Dae Jung Kim; Joo Hee Kim; Jeong-Sik Yu; Jae-Joon Chung
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 10.  Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.

Authors:  Yee Liang Thian; Angela M Riddell; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.